Your browser doesn't support javascript.
loading
CXCL10 is a novel anti-angiogenic factor downstream of p53 in cardiomyocytes.
Wahyuni, Tri; Tanaka, Shota; Igarashi, Ryuta; Miyake, Yoshiaki; Yamamoto, Ayaha; Mori, Shota; Kametani, Yusuke; Tomimatsu, Masashi; Suzuki, Shota; Yokota, Kosei; Okada, Yoshiaki; Maeda, Makiko; Obana, Masanori; Fujio, Yasushi.
Afiliação
  • Wahyuni T; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Tanaka S; Laboratory of Pharmacology and Toxicology, Faculty of Pharmacy, Universitas Indonesia, Depok City, West Java, Indonesia.
  • Igarashi R; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Miyake Y; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Yamamoto A; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Mori S; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Kametani Y; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Tomimatsu M; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Suzuki S; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Yokota K; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Okada Y; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Maeda M; Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Obana M; Laboratory of Clinical Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
  • Fujio Y; Medical Center for Translational Research, Department of Medical Innovation, Osaka University Hospital, Suita City, Osaka, Japan.
Physiol Rep ; 10(9): e15304, 2022 05.
Article em En | MEDLINE | ID: mdl-35542987
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Miócitos Cardíacos / Quimiocina CXCL10 Limite: Animals Idioma: En Revista: Physiol Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Miócitos Cardíacos / Quimiocina CXCL10 Limite: Animals Idioma: En Revista: Physiol Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão